Addus HomeCare (NASDAQ:ADUS) Upgraded at StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUSFree Report) from a buy rating to a strong-buy rating in a research note published on Thursday.

Several other equities analysts also recently weighed in on the stock. Bank of America increased their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a buy rating in a report on Tuesday, May 7th. TD Cowen raised their target price on shares of Addus HomeCare from $105.00 to $119.00 and gave the stock a buy rating in a report on Thursday, May 9th. Oppenheimer reaffirmed an outperform rating and issued a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. Royal Bank of Canada reiterated an outperform rating and set a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. Finally, Barclays downgraded Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 target price on the stock. in a research note on Tuesday, April 23rd. One investment analyst has rated the stock with a sell rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of Moderate Buy and an average target price of $110.43.

Check Out Our Latest Analysis on Addus HomeCare

Addus HomeCare Trading Up 1.2 %

Shares of Addus HomeCare stock opened at $116.07 on Thursday. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $116.89. The firm’s 50 day simple moving average is $103.69 and its two-hundred day simple moving average is $96.65. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $1.90 billion, a price-to-earnings ratio of 28.80, a PEG ratio of 2.16 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the business posted $0.84 EPS. Analysts predict that Addus HomeCare will post 4.39 EPS for the current year.

Institutional Trading of Addus HomeCare

Several institutional investors have recently bought and sold shares of ADUS. Exchange Traded Concepts LLC lifted its position in shares of Addus HomeCare by 0.8% during the 4th quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock valued at $1,329,000 after buying an additional 113 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after purchasing an additional 161 shares in the last quarter. ProShare Advisors LLC grew its position in shares of Addus HomeCare by 7.3% in the first quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock valued at $327,000 after purchasing an additional 214 shares during the period. Pitcairn Co. grew its position in shares of Addus HomeCare by 6.2% in the first quarter. Pitcairn Co. now owns 3,840 shares of the company’s stock valued at $397,000 after purchasing an additional 225 shares during the period. Finally, Renaissance Group LLC increased its stake in shares of Addus HomeCare by 1.4% during the third quarter. Renaissance Group LLC now owns 17,200 shares of the company’s stock worth $1,465,000 after purchasing an additional 243 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.